Israel has begun human trials of a COVID-19 vaccine that scientists hope to roll out to the public next summer, with the first two volunteers receiving doses of the vaccine on Sunday.
A 26-year-old and a 34-year-old were injected with the BriLife SARS-CoV-2 vaccine, which the Israel Institute for Biological Research (IIBR) began testing on animals in March. The state-run laboratory has so far produced 25,000 doses of the vaccine to be used in human trials at the Sheba Medical Center near Tel Aviv and the Hadassah Hospital in Jerusalem.
